Neuroqore's Convertible Note Round

Neuroqore raised a round of funding on October 18, 2016. Investors include IndieBio.

NeuroQore is commercializing a new repetitive transcranial magnetic stimulation (rTMS) therapy system for treatment of drug resistant depression. rTMS is a new treatment that does not require anesthes…

Articles about Neuroqore's Convertible Note Round: